Avantor Inc (AVTR) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
Total Cash From Operating Activities Chart for Avantor Inc
Avantor Inc (AVTR) operating cash flow for FY2025 was USD 623.8M, a -25.8% change from FY2024. Avantor Inc's operating cash flow grew from USD 124.6M in 2015 to USD 623.8M in 2025 (400.6% over 10 years). Operating cash flow compound annual growth rate: 5-year CAGR of -7.7%, 10-year CAGR of 17.5%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $10.38B
- Implied Share Price
- $15.35
- Enterprise Value
- $13.37B
- Revenue (TTM)
- $6.56B
- EBITDA
- $943.70M
- Profit Margin
- -8.81%
- Trailing P/E
- —
- Forward P/E
- 16.86
- Price/Book (MRQ)
- 1.77
- Price/Sales (TTM)
- 1.58
- EV/EBITDA
- 118.46
- EV/Revenue
- 2.04
- Dividend Yield
- —
- Book Value
- $8.32
- Free Cash Flow (FY2025)
- $495.00M
- Free Cash Flow Yield
- 4.77%
Snapshot as of 8th October 2026 — not point-in-time controlled, may lag the live market by a few days.